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Comparison of reprogramming factor targets
reveals both species-specific and conserved
mechanisms in early iPSC reprogramming
Kai Fu1, Constantinos Chronis2, Abdenour Soufi3,5, Giancarlo Bonora1, Miguel Edwards4, Stephen T. Smale4,
Kenneth S. Zaret3, Kathrin Plath2 and Matteo Pellegrini1*
Abstract
Background: Both human and mouse fibroblasts can be reprogrammed to pluripotency with Oct4, Sox2, Klf4, and
c-Myc (OSKM) transcription factors. While both systems generate pluripotency, human reprogramming takes
considerably longer than mouse.
Results: To assess additional similarities and differences, we sought to compare the binding of the reprogramming
factors between the two systems. In human fibroblasts, the OSK factors initially target many more closed chromatin
sites compared to mouse. Despite this difference, the intra- and intergenic distribution of target sites, target genes,
primary binding motifs, and combinatorial binding patterns between the reprogramming factors are largely shared.
However, while many OSKM binding events in early mouse cell reprogramming occur in syntenic regions, only a
limited number is conserved in human.
Conclusions: Our findings suggest similar general effects of OSKM binding across these two species, even though
the detailed regulatory networks have diverged significantly.
Keywords: Reprogramming, iPS cells, Comparative epigenomics
Background
By expressing the transcription factors Oct4, Sox2, Klf4
and c-Myc (abbreviated as OSKM), differentiated cells
can be reprogrammed into induced pluripotent stem
cells (iPSCs) that have the ability to differentiate into
any type of cell [1, 2]. iPSC technology holds great
promise in regenerative medicine and for the modeling
of diseases in a culture dish [3, 4]. However, there is still
limited understanding of the essential mechanisms
underlying reprogramming of somatic cells to iPSCs.
Furthermore, there are marked differences in the repro-
gramming process for mouse and human cells, even
though reprogramming can be accomplished by the
same set of factors. Mouse cells reprogram within a
week or two, whereas human cells may take up to a
month and the efficiency of the conversion is typically
lower in the human system [5, 6]. Moreover, while
mouse cells can be reprogrammed efficiently with OSK
alone, ectopic c-Myc expression is more critical in the
human process [1, 2, 7]. To understand universal fea-
tures of reprogramming across species, we characterized
the differences and similarities in the regulatory
networks that were manifested at the onset of repro-
gramming of human and mouse somatic cells.
An important approach towards understanding the
reprogramming process is to systematically investigate
the binding of reprogramming factors in the genome. By
investigating OSKM binding at 48 h of reprogramming,
previous studies have begun to elucidate the patterns
and regulatory roles of OSKM in early reprogramming
in the human and mouse systems [8–10]. Reprogram-
ming typically is an inefficient process where only few
cells in the culture dish induce the pluripotency pro-
gram, yielding a highly heterogeneous cell population at
the end of the process [11]. In previous studies, Koche
et al. demonstrated that within the first few days of iPS
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reprogramming, dividing and nondividing cells exhibited
highly similar transcriptional profiles [12]. Polo et al.
showed that in the first three days of reprogramming,
cells sorted for reprogramming markers and analyzed by
transcriptomics clustered together [13]. These studies
thus indicate a significant degree of homogeneity in cel-
lular responses during the early time scale of reprogram-
ming, enabling location studies of OSKM in the early
reprogramming population. Moreover, for the 48-h time
point in mouse, we used fetal bovine serum containing
media, which results in iPSC colonies within 2–3 weeks.
In these conditions, the timing of reprogramming is
similar to that found in human experiments. The early
human and mouse cells are thus expected to be in a
similar stage of reprogramming. However, the final iPSC
stage between human and mouse is significantly diffe-
rent: the human cells are reprogrammed to a primed
stage while the mouse cells are reprogrammed to a naïve
stage [14]. For those reasons, in this study we focused
on the 48-h comparison instead of the iPSC stage of
reprogramming.
In this study, we compared the initial OSKM binding
events between human and mouse fibroblasts to shed
light on both conserved and species-specific mecha-
nisms of OSKM-mediated processes early in reprogram-
ming. The mouse system used transgenic mouse
embryonic fibroblasts, thus every cell expresses the four
factors [10]. Similarly, in the ectopic expression of
OSKM in human fibroblast, each of the factors were
shown to be expressed in 97–99% of the cells [8]. Thus,
it is unlikely that heterogeneity in expression will lead to
differences between the mouse and human systems
being studied. Moreover, by focusing on the binding
events of OSKM early in reprogramming, we guaranteed
minimal influence of the differences between human
and mouse cell reprogramming that resulted in mouse
iPSCs in the naïve pluripotent state and human iPSCs in
the primed pluripotent state caused by the external
culture conditions.
We first show that general features of OSKM binding
events, such as inter- and intragenic distribution, target
genes, primary binding motifs, and combinatorial binding
patterns between the reprogramming factors, are largely
similar between human and mouse. However, when we
compared the locations of OSKM binding events, we
found that only a small fraction of binding sites in
syntenic regions were conserved between human and
mouse at 48 h of reprogramming. This result indicates
that the binding of the reprogramming factors is in large
part distinct at the initial stage of the reprogramming
process. We show that conserved binding events within
syntenic regions often represent target sites that are also
bound in the pluripotent end state and tend to occur in
promoters and enhancers, suggesting that the engagement
of pluripotency sites early in reprogramming is a con-
served mechanism between mouse and human repro-
gramming. Lastly, we show that both motif usage and
chromatin states contribute to the conservation of binding
events in early human and mouse reprogramming.
Results
General features of OSKM binding events in early human
and mouse reprogramming
In this study, we compare the binding of OSKM peaks in
mouse and human at 48 h post transfection. This is accom-
plished by analyzing previously published datasets [8, 10].
We note that there are some differences in the mouse and
human datasets that are due to the difference in overex-
pression methodology and the starting cell type. While the
mouse data was generated by overexpressing the pluripo-
tency factors using a polycistronic cassette (ensuring that
each cell expresses all four factors at comparable levels), the
human data was generated using individual lentiviral vec-
tors, which leads to more variability in the combination
and level of expression of the factors. However, as we show
below, these differences do not have a significant impact on
our conclusions.
We first addressed the effects of overexpression between
polycistronic and individual based approaches. While the
primary results presented in Chronis et al were based on a
polycistronic cassette [10], in the same study we also col-
lected binding data generated by individually overexpress-
ing factors using pmX. We showed that in mouse,
individual retroviral based expression of Oct4, Sox2 and
Klf4 (OSK) have strong signals in the polycistronic derived
OSK peaks, indicating that the OSK signal from the two
systems are enriched in similar genomic loci (Additional file
1: Figure S1). In addition, the two protocols yielded
significant number of overlapped peaks (Additional file 1:
Figure S2). Moreover, we note that while the mouse experi-
ments were carried out in embryonic fibroblasts, the hu-
man studies were done in fetal foreskin fibroblast. Since we
did not have access to epigenomes from both embryonic fi-
broblasts and fetal foreskin fibroblasts in either human or
mouse, we were not able to compare the potential differ-
ences between the two starting cell types. Nonetheless, we
do have access to epigenomes for both human foreskin
newborn and human lung fetal fibroblasts from Roadmap
Epigenomics Project. To address the potential differences
between different types of fibroblasts, we used DNaseI
hypersensitive sites to represent the chromatin states and
then compared their overlapping. Additional file 1: Figure
S3 then shows that although there are differences, the two
types of fibroblasts have a significantly overlapped number
of DNaseI peaks, suggesting the overall similarities of
chromatin states between those two types of fibroblasts.
Having shown that these two experimental strategies
yield similar OSKM binding events, we chose to focus
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our analyses on the mouse polycistronic and human
individual lentiviral cassette where all our ChIP-Seq was
collected. To further enable their comparison, we gene-
rated OSKM peaks for both human and mouse cells
reprogramming using the same analysis pipeline for
mapping and peak calling, setting the peak calling
q-value cutoff of 0.05 (see Methods).
The human and mouse data sets generated a similar num-
ber of peaks for Oct4, while the early human reprogram-
ming culture had about twice as many peaks for the other
three factors compared to the mouse (Additional file 1:
Figure S4). We then first asked whether OSKM peaks had a
similar positional distribution with respect to transcriptional
start sites (TSSs) in the two species (Fig. 1a). Specifically, we
classified the distances between peaks and TSSs into differ-
ent groups, i.e. 0 to 5 kb, 5 to 50 kb etc. As has shown before
[8, 10], O, S and K in both human and mouse predomin-
antly bind regions distal to TSS. However, in humans M
tends to bind distally to the TSS whereas in mouse it tends
to bind proximal to TSS regions. This result is consistent
with previous finding that M has a different distribution be-
tween human and mouse [8, 10] (Fig. 1a).
We next compared the target orthologous genes for
each factor between human and mouse reprogramming.
Targets were defined as an orthologous gene whose TSS
is closest to the peaks for each factor irrespective of
binding distance. We then calculated the number of
overlapping target genes among the four factors in the
two species and found that a large fraction of ortholo-
gous genes was targeted by the four factors in both spe-
cies (Fig. 1b). Furthermore, among the 8433 OSKM
co-targeted genes in human and 6867 co-targeted genes
in mouse, 3919 of 15,789 orthologous genes were shared
significantly (p-value < 10− 16, hypergeometric test), indi-
cating a significant number of OSKM co-targeted genes
were conserved, even though there was still a large set
of genes were not shared between the species. Gene
ontology enrichment analyses showed those shared
co-targeted genes were enriched in the biological pro-
cesses of regulation of macromolecular metabolic
process, regulation of transcription, in utero embryonic
development and regulation of Wnt signaling pathway
(Fig. 1c). This agrees with previous studies which
showed that the Wnt signaling pathway modulated re-
programming efficiency when altered early in repro-
gramming [15].
We next carried out de novo motif discovery in each
factor’s binding regions (see Methods). The DNA bind-
ing motifs we identified for each reprogramming factor
was similar between human and mouse (Fig. 1d). We
also observed minor motif differences in Oct4, which
terminated with A/T AA in mouse but A/G C/T AT in
A
B
C
D
E
Fig. 1 General feature comparison of OSKM ChIP-Seq peaks between human and mouse 48 h fibroblast reprogramming. a Positional distribution
of OSKM peaks with respect to Transcription Start Sites (TSSs). The top panel shows the peaks in human while the bottom panel shows that in
mouse. b Venn diagram of OSKM co-targeted genes in human (left panel) and in mouse (right panel). c Enriched gene ontology terms (biological
process) of shared OSKM co-targeted genes between mouse and human. d De novo and canonical motifs of OSKM peaks. e Log2 ratio of
observed combinatorial binding events versus expected
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human, as well as in c-Myc, which terminated with C G/
A TG in mouse but C/T G T/C G in human. We further
used STAMP, which is a web tool for exploring
DNA-binding motif similarities, to compare the repro-
gramming factor motifs between human and mouse
[16]. As a result, the motif similarity E-value was 1.14e−
7, 3.72e− 8, 3.44e− 11, 1.56e− 8 for O, S, K and M factor re-
spectively. Thus, the motifs between human and mouse
were significantly similar. Moreover, de novo motifs of
the four factors were largely consistent with their
canonical motifs (obtained from Jaspar database) [17],
indicating DNA binding preferences of O, S, K, and M
are largely conserved between human and mouse.
To further characterize OSKM binding, we identified all
possible combinations of binding events. If summits of
peaks from different reprogramming factors were within
100 bp of each other, we considered them to be “co-”
binding events. If summits of peaks from one factor were
at least 500 bp away from all other factors, we defined
these as “solo” binding events. To gauge whether
co-bound sites occurred more or less frequently than ex-
pected, we compared our counts to a synthetic null model
for all possible combinations of factors (see Methods). We
found that in both human and mouse, all co-binding
events occurred more frequently than expected, whereas
solo binding sites were observed less frequently than ex-
pected (Fig. 1e). OSKM, OSK, OSM, OKM and SKM
co-binding events were the most prevalent combinations
in both human and mouse. Moreover, solo binding sites
were more likely in human than in mouse and nearly all
co-binding events (except KM and OKM) were more
prevalent in mouse. Regardless of the differences, these re-
sults indicate that O, S, K, and M tend to bind together
with similar combinatorial patterns in both human and
mouse, suggesting that the factors often co-bind to exert
their actions. Overall, we conclude that the general prop-
erties of O, S, K and M are similar, although there are
some observable differences.
Comparison of OSKM binding to the chromatin state of
starting cells
Next, we sought to compare the chromatin state in the
starting cells for OSKM binding sites at 48 h between hu-
man and mouse. This enabled us to see how OSKM inter-
acted with the initial chromatin states in fibroblasts. We
analyzed H3K4me1, H3K4me3, H3K27me3, H3K27ac and
H3K36me3 histone marks of human fibroblasts from the
Roadmap Epigenome Project [18] and of mouse fibro-
blasts [10] to build a 15 chromatin state model using
ChromHMM [19] with a concatenated human-mouse
genome (see Methods). Based on the combinatorial prob-
ability of the five histone marks, we classified the mouse
and human genomes into chromatin states such as active
promoter and active enhancer. We chose a model with 15
chromatin states because these had a clearly distinct com-
bination of histone marks and functional annotations
based on prior expectations. The genomes of both human
and mouse were segmented into non-overlapping 200 bp
regions, and each bin associated with a specific chromatin
state. Figure 2a shows the emission probabilities (signal en-
richments) of each histone mark as well as the fractions of
the genome (numbers in the brackets, human followed by
mouse) that each chromatin state occupies in human and
mouse fibroblasts. We noted primary differences between
human and mouse chromatin states including the fre-
quency of the two H3K9me3-containing chromatin states,
weak repressed polycomb and quiescent chromatin state,
where human fibroblasts had significantly more genomic
regions annotated as ZNF/repeats and heterochromatin
and less genomic regions annotated as the latter two states.
A
B
C
Fig. 2 OSKM peaks target of the chromatin states in starting cells. a Chromatin state model for concatenated human and mouse fibroblast cells
based on five histone marks. The value in the heatmap represents the enrichment of that histone mark in that learned chromatin state. The
values in the bracket represent the genomic percentage (human then followed by mouse) occupied by that chromatin state. b Heatmap for
percentages of OSKM peaks in each chromatin states from a. c Heatmap for log2 enrichments between OSKM peaks percentages and chromatin
state genomic percentages
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By intersecting OSKM peaks with chromatin states,
we calculated the percentage of peaks within chromatin
states in both human and mouse (Fig. 2b). As a result,
about 40~50% of human O, S, and K peaks, and 20% of
human M peaks were within low signal regions (states
14 and 15). This chromatin analyses agrees with a direct
assessment of the individual histone modification states
targeted by OSKM, which showed that O, S, and K pre-
dominantly target unmarked chromatin sites [8]. By con-
trast, in mouse, the percentage of low signal regions
targeted decreased to 20% for O, S, and K peaks and 2%
for M peaks. In addition, about 40~50% of mouse O, S,
and K peaks and 30% of M peaks were within enhancers,
consistent with the finding that mouse OSK efficiently
target enhancers active in fibroblasts early in mouse re-
programming [10]. However, for human O, S and K
peaks, this number dropped to about 10%~ 25% and M
peaks showed a similar number of 30%. After correction
for the genome percentage annotated as different
chromatin states, the human peaks were still more
enriched in low signal regions and less enriched in en-
hancer regions (Fig. 2c). Those results reveal a distinct
distribution of OSKM in chromatin states of low signals
and enhancers between human and mouse.
OSKM binding events show limited conservation between
human and mouse
To further compare OSKM occupancy in early mouse and
human cell reprogramming, we mapped mouse peaks to
the human genome based on synteny (see Methods).
Mouse peaks were classified into three groups based on se-
quence conservation and binding conservation. Figure 3a
shows a schematic illustration of the definition of the three
groups: syntenic conserved peaks, syntenic unconserved
peaks, and unsyntenic peaks. Syntenic conserved (SC)
peaks had orthologous DNA sequences as well as binding
events in both organisms. Syntenic unconserved (SU) peaks
only had orthologous DNA sequences but no binding event
A
C
E
B
D
F
Fig. 3 Map OSKM binding between human and mouse. a Schematic illustration of the three different groups of peaks, i.e. Syntenic Conserved (SC) binding
group, Syntenic Unconserved (SU) binding group and UNsyntenic (UN) binding group. b Percentage of mouse OSKM peaks that can be mapped to human.
The background is calculated by the simulation of peaks that have the same size and same number as the real peaks, and are allowed to map anywhere on
the genome. c Fractional constitutions of SC, SU and UN peaks for each factor. d Percentage of SC binding events with respect to all syntenic binding events.
For each factor, syntenic peaks are classified into four groups based on their peak enrichments of -log10(q-value). 0–25% are the top 25% of peaks while
75–100 are the bottom 25% of peaks. e Percentage of the three groups of peaks that contain repeat sequences. f Percentages of mouse peaks that contain
specific type of mouse repeat sequences. Seven major types of repeat, i.e. DNA (DNA transposon elements), LINE (Long interspersed nuclear elements), LTR
(Long terminal repeats), Retroposon (Transposons via RNA intermediates), Satellite (Satellite DNA which belongs to tandem repeats), Simple (Simple repeats)
and SINE (Short interspersed nuclear elements) are calculated
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detected in human. Unsyntenic (UN) peaks did not have
orthologous DNA sequences between organisms and there-
fore could not be mapped between human and mouse.
We found that about 74, 80, 73 and 89% of mouse O, S,
K, and M peaks, respectively, were syntenic with human,
while the background ratio for the entire genome was
about 40% (Fig. 3b), indicating that elements bound by
OSKM show much higher sequence conservation rates
than the rest of the genome, consistent with OSKM bind
to cis-regulatory events such as enhancers and promoters.
However, for each reprogramming factor, we found that
syntenic conserved peaks only represented a small fraction
of peaks (Fig. 3c). Specifically, 4, 4.5, 10.9 and 34.4% of
mouse O, S, K, and M peaks, respectively, were syntenic
conserved. O, S, and K, which mostly bind to enhancer
regions in mouse (Fig. 2b) [10], had a lower fraction
of conserved peaks compared to M, which mostly
binds to promoter regions in early mouse cell repro-
gramming (Fig. 2b) [10]. We then asked whether the
limited degree of conservation between mouse and
human binding events could be solely explained by
random background binding events between human
and mouse. To address this we simulated both human
and mouse background peaks (same number and
length with the observed ones), then calculated the
conservation rate and repeated the simulation 1000
times. The simulation result showed a conservation
rate for OSKM background peaks of approximately
1%, implying that although the fraction of conserved
binding was relatively small, conserved binding events
still occurred at a higher rate than expected by
chance. Lastly, we also mapped mouse pMX peaks
(individual retroviral based system) to human peaks.
Consistent with the comparison between polycistronic
peaks in mouse and lentiviral peaks in human, our
result showed that there was a limited fraction of
syntenic conserved peaks for Oct4, Sox2 and Klf4
(Additional file 1: Figure S5). This result also indi-
cates that the divergence of binding between human
and mouse is not affected by using different overex-
pression systems.
In a previous study, Cheng et al. showed that the degree
of binding conservation varied markedly, from several
percent to about 60%, between human and mouse among
different transcription factors (TFs) [20]. In addition, pro-
moter bound TF binding sites showed higher conservation
rates than enhancer sites. Moreover, this trend held after
adjusting the sequence conservation differences between
promoters and enhancers, indicating that the TF binding
sites in promoter regions are indeed more conserved than
those in enhancer regions [20]. In another study, Schmidt
et al. reported a 10 to 22% binding conservation rate
between two of five mammals for liver-specific transcrip-
tion factors [21]. In early reprogramming, we observed a
low conservation rate for O, S, and K and a medium con-
servation rate for M (Fig. 3c), indicating the significance of
binding divergence in early reprogramming system between
human and mouse fibroblasts.
We next investigated whether peak binding strength
(based on peak calling q-values) had an impact on con-
servation. We classified all mouse peaks into four groups
based on their -log10 q-values (Fig. 3d). For each repro-
gramming factor, we observed a clear trend where the
strongest peaks (top 25%) had a higher percentage of
syntenic conserved binding events compared to other
three groups. This result suggests peak binding strength
indeed is positively correlated with peak conservation
rates and stronger peaks tend to be more conserved.
By analyzing the presence of repeat sequences within
the three groups of peaks (see Methods) (SC, SU, and
UN), we found that the unsyntenic peaks had a much
higher percentage of repeat sequences compared to the
other two groups for all factors. In addition, except for
Sox2, syntenic conserved binding sites contained the
fewest repeats (Fig. 3e). Moreover, compared to peaks in
syntenic regions, peaks in unsyntenic regions were more
often associated with long terminal repeats (LTR) and
short interspersed nuclear elements (SINE) and less
often with simple repeats in the mouse genome (Fig. 3f ).
These results are consistent with previous findings
which showed that transposable elements are enriched
in species-specific sequences and have rewired the tran-
scriptional network during evolution [22, 23].
The analyses described above were carried out by
mapping mouse OSKM peaks to the human genome,
but we also performed the inverse analysis by mapping
human OSKM peaks to the mouse genome (Additional
file 1: Figure S6a). Approximately 60% of human peaks
occurred in genomic regions syntenic with the mouse.
The lower syntenic rate of human peaks mapping to the
mouse genome compared with mouse peaks mapping to
the human genome correlated with a higher proportion
of repeats in human peak sequences (Additional file 1:
Figure S7). Among human OSKM peaks in syntenic
regions, those also found in the mouse (syntenic
conserved) constituted a small proportion as seen in the
reverse mapping of mouse OSKM peaks to the human
data (Additional file 1: Figure S6b). Interestingly, syn-
tenic and unsyntenic human OSKM peaks showed a
more similar distribution of certain types of repeats
compared to mouse peaks (Fig. 3f, Additional file 1:
Figure S8).
We also investigated how human syntenic peaks and
all peaks of mouse were distributed relative to each
other. We first calculated the distances between human
syntenic peak summits and mouse peak summits. We
then categorized the distances into several groups of
genomic ranges, i.e. within 200 bp, 400 bp, 600 bp, 800
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bp etc. Lastly, to compare the observed distance distri-
bution with simulated background, we calculated the
background distance distribution, where the mouse
peaks were shuffled and the human syntenic peaks were
kept fixed. The result suggests that observed human syn-
tenic peaks are indeed closer to observed mouse peaks
than expected by chance (Additional file 1: Figure S9).
Moreover, there was a clear trend showing that the log2
ratio between observed and simulated peaks declined
with increased distance. Among the four factors, c-Myc
showed the most dramatic trend. This is consistent with
the fact that c-Myc is the most conserved factor com-
pared to the other three.
Syntenic conserved peaks are associated with different
genomic features compared with unconserved peaks
Since we observed that only a small fraction of syntenic
peaks had conserved binding early in reprogramming in
human and mouse cells, we sought to identify properties
that distinguish conserved peaks from the others. We
observed that syntenic conserved peaks had significantly
higher ChIP enrichment (−log10 q-value) than the other
two groups (Fig. 4a), indicating the SC peaks tend to be
bound more strongly. We then used the GREAT tool
[24] to perform gene ontology enrichment analysis for
the mouse SC, SU, and UN peaks, with all peaks as
background (Fig. 4b). For SC peaks of OSM, we found
their target genes were enriched for fat pad, adipose tis-
sue, and adrenal gland development. Surprisingly, for SU
peaks no enriched gene ontology terms for any of the
four factors were detected. UN peaks of OSKM were
strongly enriched in immunity-related gene ontologies.
These results suggest that the target genes of the three
groups of peaks might be associated with distinct func-
tions. When comparing the genomic locations of mouse
SC peaks to all peaks with respect to the distance to the
TSSs, we found that SC O, K, and M peaks more often
occurred within the proximal TSS regions, while Sox2
was slightly more often within the distal TSS regions
(Fig. 4c).
We also compared binding of mouse OSKM at 48 h with
that in the pluripotent state, to define those mouse OSKM
binding events that were bound both early in reprogram-
ming and in the pluripotent state (based on mouse embry-
onic stem cell ChIP-seq data) versus those that only occur
at 48 h but not in pluripotent cells (Fig. 4d,i) [10]. In our
previous study, we described that many of these persistent
binding events for OSKM were enriched in promoters and
A
B
C
D
E
Fig. 4 Comparisons of syntenic conserved peaks with syntenic unconserved peaks and unsyntenic peaks. a Box plot of peak calling q-values for the
SC, SU and UN groups of peaks. b Enriched gene ontology terms for SC, SU and UN groups of peaks. c Fold enrichment of positional distribution
between SC peaks and all peaks around Transcription Start Sites. d Percentage of SC, SU and UN peaks with consecutive bindings. 48 h only represents
the peaks that only bound in 48 h of reprogramming, while 48 h and pluripotent represents the peaks that are also bound in the reprogramming final
stage. i represents the number of the two group of peaks. ii-iv represents the percentage of SC, SU and UN peaks that are either 48 h only bound or
48 h and pluripotent bound. e Heatmap for percentages of mouse SC, SU and UN peaks in the mouse 18 chromatin states
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OSK were also highly enriched in pluripotency enhancers
[10]. We calculated the percentage of SC peaks that were
bound only early in reprogramming or persist throughout
reprogramming. We found that compared with SU and UN
peaks, mouse SC peaks of OKM at 48 h had a higher frac-
tion of persistent binding events (Fig. 4d,ii-iv). Specifically,
for Oct4, the percent of persistent bound events was 20, 9
and 14 for SC, SU and UN respectively. For Klf4, this
percent was 56, 17 and 23, and for c-Myc, this percent was
59, 10 and 22. This result indicates that conserved binding
events, especially for K and M, tend to be maintained
during reprogramming and are therefore likely to be more
functionally important than unconserved ones.
We next asked whether SC, SU and UN peaks had dis-
tinct patterns of chromatin states in mouse at 48 h. A
mouse 18 chromatin state model was generated with
nine histone marks and described in our previous paper
(Additional file 1: Figure S10) [10]. We therefore calcu-
lated the percentage of peaks within each chromatin
state (Fig. 4e). As a result, we found that SC peaks pref-
erentially tended to occur within certain chromatin
states compared to SU and UN peaks. Specifically, SC
peaks of O, K and M had higher percentages within ac-
tive promoters, bivalent promoters and certain groups of
enhancers. By contrast, UN peaks of O, S and K had
higher percentages within low signal regions. Those
results indicate that different groups of peaks are likely
to associate with different chromatin states.
Using transitions of regulatory motifs and chromatin
states as predictors of conserved binding
To further investigate the chromatin states of syntenic
peaks, we performed another comparison from a
human-mouse transition perspective. We assigned each
syntenic peak to the chromatin state in the concatenated
human and mouse genome (Fig. 2a) and compared the
chromatin assignment of each SC peak between mouse
and human (see Methods) (Fig. 5a). The color in the
heatmap reflects the percentage of SC peaks within that
transition in chromatin state between the mouse and hu-
man syntenic genome. For example, the top left square
in the heatmap is the transition from human TSS re-
gions (state 1) to mouse TSS regions (state 1) and the
bottom right is the transition from human quiescent re-
gions (state 15) to mouse quiescent regions (state 15)
(i.e. no changes in chromatin state), and any deviation
from the diagonal represents a change in chromatin
state. For SC peaks of O, S, and K, the most frequent
transitions corresponded to human promoter to mouse
promoter, human enhancer to mouse promoter, human
enhancer to mouse enhancer, and human enhancer to
mouse quiescent regions. By contrast, the majority of
A
C
B
D
Fig. 5 Chromatin state transitions, motif usages and their contributions in the maintaining of syntenic conserved peaks. a Chromatin state
transitions of syntenic conserved peaks between human and mouse. The top left is state 1 of human to state 1 of mouse. The value in the
heatmap represents the fraction of the number of syntenic conserved peaks in that square divided by the total number of all syntenic conserved
peaks. b Chromatin state transitions of the log2 ratio between syntenic conserved peaks versus syntenic unconserved peaks. The value in the
heatmap represents the log2 ratio between the fraction of syntenic conserved peaks and the fraction of syntenic unconserved peaks in that
square. c Percentage of SC, SU and UN peaks that have canonical motifs. d ROC AUC of a classifier to predict syntenic based on motif
occurrences and chromatin state transitions
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frequent transitions for c-Myc involved promoter to pro-
moter states. We also asked whether the chromatin state
transition patterns were different for unconserved peaks.
When comparing the transition profiles between SC and
SU peaks (Fig. 5b), we found an enrichment in human
promoter to mouse promoter, human enhancer to
mouse promoter and human enhancer to mouse enhan-
cer transitions, indicating that SC peaks are more often
associated with certain regulatory sites in both species
than SU peaks.
Another factor that may help maintain the con-
servation of peaks is the occurrence of binding
motifs. Although we observed that SC peaks were
preferentially found within promoters and enhancers,
it was not clear whether motifs help maintain the
conservation of peaks between mouse and human.
To shed light on this question, we computed the
motif frequency in each group of peaks (see
Methods) (Fig. 5c). We reasoned that if the conser-
vation of peaks was strongly influenced by the pres-
ence of binding motifs between mouse and human,
then SC peaks should have a different fraction of
motifs compared to the other two groups. For Sox2,
53% of SC binding events had identifiable motifs
within their peaks, compared to approximately 35%
of SU and UN. However, for the other three factors,
SC peaks contained more motifs but the differences
among the three types of peaks were smaller, indi-
cating the limited impact of sequence motifs in the
determination of binding conservation.
To quantitatively assess the extent to which SC peaks
are determined by motifs or chromatin states, we built a
naïve Bayesian classifier to evaluate the prediction power
for classifying syntenic peaks into the SC and SU groups
(see Methods). This model was trained using different
sources of information: motif only, chromatin state only,
and the two combined. Area under the curve (AUC)
values of receiver operator curves (ROC) were used to
estimate the prediction power (Fig. 5d and Additional
file 1: Figure S11). We found that except for Sox2, the
chromatin state only model outperformed the motif
only model. Moreover, when combining information
from both motif and chromatin states, the AUC for
O, S, K, and M were 0.63, 0.71, 0.90, and 0.71 re-
spectively. Klf4 showed a strikingly high prediction
power due to its strong motif preference in syntenic
regions between human and mouse and its strong
chromatin state preference for specific chromatin
state transitions. Although the models for O, S, and
M only predicted a fraction of conserved sites, these
results demonstrate that conserved peaks are indeed
associated with syntenic regions that contain strong
motif sequences and preferred chromatin state transi-
tions between mouse and human.
Discussion
In this study, we systematically compared binding pat-
terns of the four reprogramming factors OSKM between
human and mouse at an early time point of reprogram-
ming to the iPSC state. When analyzed in each genome
separately, OSKM binding sites in human and mouse
shared similar features: OSK tend to bind distal TSS re-
gions, OSKM tend to target similar genes, have similar
DNA binding motifs, and show similar combinatorial
binding patterns among the reprogramming factors. This
suggests that molecular properties of these factors are
conserved between human and mouse. However, differ-
ences emerged when we investigated the chromatin state
of target sites: OSKM targeted far more closed (low sig-
nal state) chromatin states in human cells than in
mouse. Importantly, when we compared the binding
sites across syntenic regions, we found that there was
only a small percentage of sites that were bound in both
genomes (i.e. syntenic conserved, SC). Altogether, our
results suggest that the initial OSKM binding sites are
largely distinct in these two species, even though the
phenotypic consequences of these interactions ultimately
lead to similar cell types.
We also observed that most early binding events do
not persist in the later stages of iPSCs reprogramming
[10]. However, we found that binding events that were
conserved between mouse and human tended to persist
more often throughout the reprogramming process
compared to unconserved sites. Conserved binding sites
also tended to have a higher proportion of conserved
cis-regulatory elements associated with each factor. We
also showed that binding sites were more likely to be
conserved if the mouse and human chromatin states
were similar and the motifs were conserved.
We recognize that there are certain limitations to our
analysis. One is that human and mouse reprogramming
was performed using slightly different experimental proto-
cols. An inducible polycistronic cassette including all four
reprogramming factors was used in mouse fibroblasts, en-
suring homogeneous expression and stoichiometry across
the cell population at 48 h; whereas four separate lentiviral
constructs were used in human, each expressing one factor.
However, as we have shown by comparing mouse polycis-
tronic to individual cassettes, these different overexpression
methods lead to very similar binding peaks. Also, it is pos-
sible that at 48 h, human and mouse cells might not be in
the same reprogramming stages due to their different re-
programming kinetics. However, the time point we used
corresponds to early events in the time series of both spe-
cies, and should, therefore, identify the first interactions of
these factors with chromatin. Moreover, we compared
mouse embryonic fibroblasts and human fetal foreskin fi-
broblasts as starting cells of reprogramming. However, we
believe that the epigenome changes from embryonic to fetal
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stages of fibroblasts are unlikely to have a dramatic effect
on OSKM binding patterns. As a result, our conclusions
drawn from the comparison of these two species should
not be significantly affected by the differences in the experi-
mental details of the human and mouse systems.
In conclusion, we have shown that while some general
properties of OSKM binding are conserved between
mouse and human, the specific genomic locations of
transcription factor binding sites are vastly reorganized.
A subset of the binding events are syntenic between the
two species and this study has allowed us to identify
these. We do not know if they represent key events that
are distinct from the large fraction of other binding sites
that are not conserved. However, several lines of evi-
dence that we have presented, such as the fact that these
sites tend to persist throughout the reprogramming
process, do suggest that these may play a more signifi-
cant role in reprogramming than the typical uncon-
served site. Nonetheless, the overall picture that emerges
is that the OSKM regulatory networks have significantly
diverged between the two species, and while the general
properties of these networks are similar, the specific
binding sites are generally distinct. This observation may
suggest that reprogramming to pluripotency may be
driven by global regulatory changes in cells that do not
depend critically on a small set of specific interactions.
Conclusions
By systematically compare the binding of the reprogram-
ming factors, we are able to shed light on both conserved
and species-specific mechanisms of OSKM-mediated pro-
cesses early in reprogramming. In brief, there are mainly
four significantly novel findings in this study. First of all,
we found that general properties of reprogramming fac-
tors are largely shared between human and mouse in early
iPSC stage. Secondly, the reprogramming factors initially
target distinct chromatin states and induce different ex-
pression changes between human and mouse. Thirdly,
only a small fraction of reprogramming binding events are
conserved in early reprogramming. Lastly, the conserved
binding events tend to represent the targets of the repro-
gramming factors in the pluripotent end state and could
be partially predicted based on the presence of DNA
motifs and chromatin states. Altogether, these findings
suggest a similar mechanism in molecular properties per-
spective while the actual regulatory network of the pluri-
potency factors has been diverged significantly between
the two species.
Methods
Cell culture and reprogramming
In the human reprogramming system, BJ fibroblasts
were purchased from ATCC (CRL-2522) at passage 6
and cultured in the ATCC-formulated Eagle’s Minimum
Essential Medium supplemented with 10% fetal bovine
serum at 37 C and 5% CO2. The human H1-ES line [25]
were purchased from ATCC and maintained as
described [26]. More information about experimental
details can be found in the supplementary documents of
Soufi et al. 2012 [8]. In the mouse reprogramming sys-
tem, the mouse embryonic fibroblasts were obtained
from day 13.5 embryos of timed mouse pregnancies.
The mouse embryos were obtained from Laboratory of
K. Plath, where a cross between tetO OSKM/tetO
OSKM and R26-M2rtTA/M2rtTA mice. The same mouse
embryos were also used in Chronis et al. In addition, mouse
embryonic fibroblasts carrying a polycistronic, dox-inducible
OSKM cassette in the Col1A locus and a heterozygous
M2rtTA allele in the R26 locus, were grown in standard
mouse ESC media containing knockout-DMEM, 15% fetal
bovine serum, recombinant leukemia inhibitory factor (Lif),
b-mercaptoethanol, 1x penicillin/streptomycin, L-glutamine,
and non-essential amino acids. Repogramming was induced
by the addition of 2μg/ml doxycycline. We generated mouse
iPS cell lines as described [27, 28]. Briefly, BJ cells at passage
10 were infected with lentiviruses encoding for dox-indu
cible Oct4, Sox2, Klf4, and c-Myc, along with lentiviruses
expressing rtTA2M2 in the presence of 4.5mg/ml poly-
brene. Additional experimental details can be found in the
supplementary documents of Chronis et al. 2017 [10].
Mapping and peak calling
The human OSKM ChIP-Seq datasets were downloaded
from GEO with accession number of GSE36570, while
mouse OSKM ChIP-Seq datasets were downloaded from
GEO with accession number of GSE90895. Bowtie (ver-
sion 0.12.8 and default parameters) was used to map
ChIP-Seq reads of both human and mouse to their re-
spective genomes. Only uniquely mapped reads were kept
for further analysis [29]. MACS2 2.1.0 was used to identify
ChIP-Seq peaks with a q-value cutoff of 0.05 (other pa-
rameters are in default) [30]. The human genome version
is hg19 and the mouse genome version is mm9.
Motif finding and motif occurrences within peaks
MEME-ChIP was used to perform de novo motif finding
for OSKM binding peaks [31]. To identify the strongest
motifs, the identified summits of peaks were ranked
based on their enrichments and the top 10,000 summits,
along with their surrounding 200 bp, were used as the
input regions. The enriched motifs were identified using
the DREME algorithm in the MEME-ChIP software.
Starting with the most significant motif for each factor,
we then used the Position Weight Matrix of this motif
to scan for peaks, and determined the peaks associated
with this motif using a p-value cutoff of 0.001.
Fu et al. BMC Genomics          (2018) 19:956 Page 10 of 13
Combinatorial binding and solo binding
To identify combinatorial binding regions where multiple
factors bind, peaks were merged if their summits were
within 100 bp of each other. Then these different com-
binations of binding sites were broken down into their dif-
ferent combinations of factors. To identify solo binding
regions where only one factor bound, we required that its
summit be at least 500 bp away from all other factors.
Note that this method is more stringent than that used by
Soufi et al. [8]; the latter considered solo binding events as
simply not falling within 100 bp of the peak center. Here,
to estimate the background rates of combinatorial bind-
ing, the peaks of OSKM were first randomly shuffled in
the genome (using the bedtools shuffle function) [32]. Se-
condly, the expected number of combinatorial binding
events was re-calculated based on these shuffled peaks.
Lastly, we compared the number of observed binding
events versus the number of expected binding events for
all possible combinations of factors.
Mapping sequences between human and mouse
To map OSKM binding sites between human and
mouse, the liftOver algorithm from the UCSC Genome
Browser was used with a cutoff of 0.5. The LiftOver al-
gorithm uses an alignment chain file to map genomic
coordinates between different versions of assemblies, or
different species. The algorithm searches for regions
where the input sequences are in the same block with
the converted assemblies or species. The cutoff of 0.5 re-
quires that the mapped sequences share at least half of
exactly same DNA sequences with the converted species.
This cutoff is consistent with modENCODE project
paper which compares transcription factor binding sites
between human and mouse [20]. To confirm the reliabil-
ity of our results, we also used another method named
bnMapper and got very similar results [33].
Peaks associated with repeat sequences
Repeat sequences were downloaded from the RepeatMas-
ker database. We extracted the genomic coordinates for the
major repeat families including DNA (DNA transposon ele-
ments), LINE (Long interspersed nuclear elements), LTR
(Long terminal repeats), Retroposon (Transposons via RNA
intermediates), Satellite (Satellite DNA which belongs to
tandem repeats), Simple (Simple repeats) and SINE (Short
interspersed nuclear elements). A peak was considered to
be associated with a repeat sequence if the genomic coor-
dinate of this repeat was within this peak.
Chromatin states for concatenated human and mouse
genomes
For mouse histone marks, we used the datasets for
mouse fibroblast cells from our previously published
paper [10]. For human histone marks, we used the
datasets of IMR90 fibroblast cell line downloaded from
RoadMap Epigenomics Project [18]. To learn the joint
chromatin state for human and mouse, a pseudo chromo-
some size table was constructed by concatenating human
and mouse genomes. Then the model was trained with
the human fibroblast and mouse embryonic fibroblast his-
tone data, producing a common set of emission probabi-
lities. We then generated a 15 chromatin state model
based on the combinatorial patterns of five histone marks,
i.e., H3K4me1, H3K4me3, H3K27me3, H3K27ac and
H3K36me3.
Chromatin state transitions between human and mouse
Each syntenic conserved peak in mouse and its corre-
sponding orthologous peak in human was assigned a
chromatin state as described above. We then calculated
the number of peaks within each possible chromatin
state transition. This leads to the generation of a 15 X
15 chromatin state transition matrix. For example, the
top left of the matrix represents the fraction of syntenic
peaks with state 1 of human and state 1 of mouse. We
also performed the same calculation for syntenic uncon-
served peaks between human and mouse. To compare
to relative enrichment of chromatin state transitions, the
log2 ratio between the syntenic conserved and syntenic
unconserved matrices was calculated.
Classification model
We built a Naïve Bayes model to classify syntenic peaks
into a syntenic conserved and syntenic unconserved
group, based on their chromatin state transition (see
above) and motif occurrences transitions. The motif oc-
currence transition matrix was a 2 X 2 matrix that rep-
resents the frequency of motif occurrences for syntenic
peaks between human and mouse. Log odds ratios were
then calculated between syntenic conserved group and
syntenic unconserved groups for both chromatin state
transition and motif occurrence transition matrices. As a
result, each peak was assigned two values: one was the
chromatin state transition log odds ratio matrix to repre-
sent the chromatin state model, and another was the
motif occurrences transition log odds ratio matrix to
represent the motif model. The two values were added
to represent both the chromatin state and motif occur-
rence model. Syntenic peaks were then ranked based on
log odds ratio values from either the chromatin state
transition matrix or motif occurrences transition matrix,
or their sum. A syntenic conserved peak was labeled as
1 and a syntenic unconserved peak is labeled as 0.
Lastly, the Area under the curve (AUC) values of the re-
ceiver operator curves (ROC) were calculated to repre-
sent the model performance for classifying syntenic
peaks into 1 or 0 given the chromatin state transitions
or motif occurrences transitions.
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